Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit

Dendritic cell-based immunotherapy in thyroid malignancies

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

Therapeutic cancer vaccines: using unique antigens

Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

Autologous dendritic cell vaccines for non-small-cell lung cancer

Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy